Workday Receives a New Rating from Top Analyst

RBC Capital analyst Ross MacMillan reiterated a Buy rating on Workday (NYSE: WDAY) yesterday and set a price target of $96. The company’s shares closed yesterday at $82.95. According to TipRanks.com, MacMillan More »

Spectrum Pharmaceuticals Gets a Buy from Jefferies

Jefferies analyst Eun Yang reiterated a Buy rating on Spectrum Pharmaceuticals (NASDAQ: SPPI) yesterday and set a price target of $7.50. The company’s shares closed yesterday at $6.61. According to TipRanks.com, Yang More »